An Exceedingly Rare Case Of Liraglutide-Induced Liver Injury

CASE REPORTS IN GASTROINTESTINAL MEDICINE(2021)

引用 1|浏览2
暂无评分
摘要
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.
更多
查看译文
关键词
liver injury,liraglutide-induced
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要